Building a Smokeless World Tadeu Marroco – Chief Executive | Javed Iqbal – Interim Chief Financial Officer This presentation does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any BAT shares or other securities. This presentation contains certain forward-looking statements, including "forward-looking" statements made within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are often, but not always, made through the use ...

Results 2025 Erik Engstrom, CEO, and Nick Luff, CFO 12 February 2026 2 Erik Engstrom, CEO 3 RELX 2025 4 DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to risks and uncertainties that could cause actual results or outcomes of RELX PLC (together with its subsidiaries, "RELX", "w ...

Full Year 2025 Results 12 February 2026 Fernando Fernandez & Srinivas Phatak 1 Safe harbour statement This presentation may contain forward-looking statements within the meaning of the securities laws of certain jurisdictions, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Words and terminology such as 'will', 'aim' ...

Investor Presentation Carl Zeiss Meditec Group 00.40 15.50 08.92 07.40 Investor Relations February 2026 15.50 00.40 15.50 00.00 06.60 05.00 08.70 Agenda | 01 | At a Glance | | --- | --- | | 02 | Strategy | | 03 | Facts and Figures | | 04 | Outlook | | 05 | Appendix | Carl Zeiss Meditec 2 00.40 00.40 15.50 08.92 07.40 00.00 06.60 05.00 08.70 Our markets benefit from structural tailwinds ZEISS ophthalmic surgical solutions cover a patient's entire ocular lifecycle Ametropia (Hyperopia, Myopia, Astigmatism) Pr ...

Q4 2025 Earnings Supplemental Data February 2026 190 250 199 0 177 79 0 104 80 Disclaimer Non - IFRS Financial Measures This document and the investor webcast include references to non - IFRS financial measures, which include : Adjusted EBITDA, Segment Adjusted EBITDA, Segment Adjusted EBITDA margin, Total Segment Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Free Cash Flow, gross cash liquidity and net cash liquidity . Grab uses Adjusted EBITDA, Segment Adjusted EBITDA, Segment Adjusted EBITDA margin, ...

Q4 2025 Earnings Conference Call NASDAQ: EQIX Presented on February 11, 2026 © 2026 Equinix, Inc. Public Disclosure Statement Forward-Looking Statements Except for historical information, this presentation contains forward-looking statements which include words such as "believe," "anticipate," and "expect." These forward-looking statements involve risks and uncertainties that may cause Equinix's actual results to differ materially from the expectations discussed in such forward-looking statements. Factors t ...

QuidelOrtho Fourth Quarter and Full-Year 2025 Financial Results February 11, 2026 QuidelOrtho – Proprietary & Confidential. | © 2025. All Rights Reserved. 2 Forward-Looking Statements and Non-GAAP Financial Measures Forward-Looking Statements: This presentation of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are any statement contained herein that is not strictly his ...

Fourth Quarter 2025 Business Review FEBRUARY 11, 2026 1 © 2026 | AURORA PROPRIETARY Cautionary statement regarding forward-looking statements This presentation contains certain forward-looking statements within the meaning of the federal securities laws. The words "believe,ˮ "may,ˮ "will,ˮ "estimate,ˮ "continue,ˮ "anticipate,ˮ "intend,ˮ "expect,ˮ "could,ˮ "would,ˮ "project,ˮ "plan,ˮ "potential,ˮ "target,ˮ and similar expressions and variations thereof are intended to identify forward-looking statements, but ...

Inspire Medical Systems, Inc. February 2026 NYSE: INSP This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including, without limitation, statements regarding potential impacts to our business associated with Inspire V reimbursement, our plans to obtain a long-term solution that would support appropriate reimbursement for Inspire V, and our ex ...

Earnings Presentation Q4 and Full-Year 2025 Results | February 11, 2026 Safe Harbor A number of forward-looking statements will be made during this presentation. Forward-looking statements are any statements that are not historical facts. These forward-looking statements are based on the current expectations of Motorola Solutions, and we can give no assurance that any future results or events discussed in these statements will be achieved. Any forward-looking statements represent our views only as of today ...